Tomford et al., 1981 - Google Patents
Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritisTomford et al., 1981
View PDF- Document ID
- 18136798275600080107
- Author
- Tomford R
- Karlinsky M
- Buddington B
- Alfrey A
- et al.
- Publication year
- Publication venue
- The Journal of Clinical Investigation
External Links
Snippet
Dietary phosphorus restriction (PR) prevents uremia in rats with nephrotoxic serum nephritis (NSN). One possible mechanism by which PR could be protective would be through the suppression of parathyroid hormone. To evaluate this possibility two separate protocols …
- 241000700159 Rattus 0 title abstract description 120
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tomford et al. | Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis | |
ANAST et al. | Impaired release of parathyroid hormone in magnesium deficiency | |
Windmueller et al. | Biosynthesis of plasma apolipoproteins by rat small intestine without dietary or biliary fat. | |
Reeve et al. | Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis | |
Schersten et al. | Relationship between the biliary excretion of bile acids and the excretion of water, lecithin, and cholesterol in man | |
Ibels et al. | Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients | |
Pertsemlidis et al. | Regulation of cholesterol metabolism in the dog: I. Effects of complete bile diversion and of cholesterol feeding on absorption, synthesis, accumulation, and excretion rates measured during life | |
Van Tol et al. | High density lipoprotein catabolism before and after partial hepatectomy | |
Nath et al. | Diet and cholesteremia: I. Development of a diet for the study of nutritional factors affecting cholesteremia in the rat | |
Farah et al. | Dose-effect relation of cholestyramine in children and young adults with familial hypercholesterolaemia | |
Kesäniemi et al. | Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. | |
AXELROD et al. | Malignant somatostatinoma: clinical features and metabolic studies | |
MORITA et al. | Vitamin D toxicosis in cats: natural outbreak and experimental study | |
HILL et al. | Adult respiratory distress syndrome associated with colchicine intoxication | |
AYALA et al. | Acute hyperphosphatemia and acute persistent renal insufficiency induced by oral phosphate therapy | |
BEN NASR et al. | Rapid (10-minute) stimulation of rat duodenal alkaline phosphatase activity by 1, 25-dihydroxyvitamin D3 | |
La Ville et al. | Inhibition of cholesterol synthesis reduces low-density-lipoprotein apoprotein B production without decreasing very-low-density-lipoprotein apoprotein B synthesis in rabbits | |
Carlson et al. | A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy | |
Herlihy et al. | Effects of Aloe vera ingestion in the rat. I. Growth, food and fluid intake and serum chemistry | |
Toda et al. | Vasculotoxic effects of dietary testosterone, estradiol, and cholesterol on chick artery | |
Zilversmit et al. | Role of the liver and intestine in the turnover of plasma phosphatides in the rat | |
GOLDMAN et al. | Growth hormone stimulation of fatty acid utilization by adipose tissue | |
Kagami et al. | Specific binding of high density lipoprotein (HDL3) is not related to sterol synthesis in rat intestinal mucosa. | |
Oates et al. | Pancreatic blood flow in the rat during enlargement, involution, and cholecystokinin treatment | |
Ritland et al. | Effect of Treatment with a Bile-sequestering Agent (Secholex®) on Intestinal Absorption, Duodenal Bile Acids, and Plasma Lipids |